Armando Orlandi
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Erbitux MEtastatic Colorectal Cancer Strategy Study (NCT02484833) | Armando Orlandi | 2015-02-01 |
Track Armando Orlandi automatically
Every clearance here is in the API, with alerts when new ones post.